Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

1:7500), NSUN6 Polyclonal antibody (Proteintech; Cat No. 17240-1-AP; 1:2000), RabbitAnti-GAPDH antibody (Bioss; bs-41373R; 1:2000), Alpha Tubulin Polyclonal antibody (Proteintech; Cat No. 11224-1-AP; ...

Get Instant Summarized Text (Gist) An AI-driven platform has been used to optimize an antibody, 3152-1142, to neutralize a wide range of SARS-CoV-2 variants, enhancing its potency against ...

#RPN2232). The antibodies used include AR antibody clone D6F11 (Cell Signaling Technology, Cat. #5153), GAPDH antibody clone 14C10 (Cell Signaling Technology, Cat. #2118), glucocorticoid receptor (GR) ...

In the rapidly evolving field of antibody drug discovery, the ability to efficiently characterize and screen antibodies and antibody drug conjugates (ADCs) is crucial for developing effective ...

The granted claims cover the novel design and therapeutic applications of bispecific antibodies that simultaneously inhibit CHI3L1 and PD1, key targets implicated in immune evasion by tumor cells.

Biologics are a wide-ranging class of drugs, and there are many different types. Most biologics for Crohn's disease are monoclonal antibody treatments that help tune down the immune system’s ...

Dr. James Hansen, a Yale Cancer Center researcher, and his team discovered that using an antibody related to lupus they can breach the tumor and trigger an immune response to fight it. He says ...

Attribution (BY): Credit must be given to the creator. Immunoreagents, most commonly antibodies, are integral components of lateral flow immunoassays. However, the use of antibodies comes with ...